TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotage Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
62,059
|
64,821
|
78,393 |
| Financial expenses |
835
|
0
|
2,698 |
| Earnings before taxes |
14,529
|
16,836
|
21,190 |
| EBITDA |
15,355
|
16,252
|
24,135 |
| Total assets |
53,017
|
60,613
|
52,127 |
| Current assets |
52,265
|
59,697
|
51,092 |
| Current liabilities |
30,984
|
23,210
|
23,937 |
| Equity capital |
21,215
|
36,613
|
27,478 |
| - share capital |
337
|
349
|
347 |
| Employees (average) |
85
|
92
|
93 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.0%
|
60.4%
|
52.7% |
| Turnover per employee |
730
|
705
|
843 |
| Profit as a percentage of turnover |
23.4%
|
26.0%
|
27.0% |
| Return on assets (ROA) |
29.0%
|
27.8%
|
45.8% |
| Current ratio |
168.7%
|
257.2%
|
213.4% |
| Return on equity (ROE) |
68.5%
|
46.0%
|
77.1% |
| Change turnover |
-558
|
-13,801
|
9,473 |
| Change turnover % |
-1%
|
-18%
|
14% |
| Chg. No. of employees |
-7
|
-1
|
-2 |
| Chg. No. of employees % |
-8%
|
-1%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.